University of Sydney spin-off Elastagen has been sold to pharma company Allergan for US$95m, with further payments if the technology reaches the market. Elastagen is a synthetic spray-on skin for use in surgical wound repair and scar remodelling. The company was founded by UniSyd biochemist Tony Weiss.